The role of human mast cells in allergy and asthma

References

• EAACI.org, EAACI global atlas of asthma 2021 update.
   Google Scholar
• Andersson CK, Bergqvist A, Mori M, et al. Mast cell-associated alveolar inflammation in patients with atopic uncontrolled asthma. J Allergy Clin Immunol. 2011;127(4):905–912.e7.
   PubMed Web of Science ®Google Scholar
• Balzar S, Fajt ML, Comhair SAA, et al. Mast cell phenotype, location, and activation in severe asthma. Am J Respir Crit Care Med. 2011;183(3):299–309.
   PubMed Web of Science ®Google Scholar
• Dahlin JS, Hallgren J. Mast cell progenitors: origin, development and migration to tissues. Mol Immunol. 2015;63(1):9–17.
   PubMed Web of Science ®Google Scholar
• Agier J, Pastwińska J, Brzezińska-Błaszczyk E. An overview of mast cell pattern recognition receptors. Inflammation Res. 2018;67(9):737–746.
   PubMed Web of Science ®Google Scholar
• Juremalm M, Nilsson G. Chemokine receptor expression by mast cells. Chem Immunol Allergy. 2005;87:130–144.
   PubMedGoogle Scholar
• Lyons DO, Pullen NA. Beyond IgE: alternative mast cell activation across different disease states. Int J Mol Sci. 2020;21(4):1498.
   PubMed Web of Science ®Google Scholar
• Gendrin C, Vornhagen J, Ngo L, et al. Mast cell degranulation by a hemolytic lipid toxin decreases GBS colonization and infection. Sci Adv. 2015;1(6):e1400225–e1400225.
   PubMed Web of Science ®Google Scholar
• Meiners J, Reitz M, Rüdiger N, et al. IL-33 facilitates rapid expulsion of the parasitic nematode strongyloides ratti from the intestine via ILC2- and IL-9-driven mast cell activation. PLoS Pathog. 2020;16(12):e1009121.
   PubMed Web of Science ®Google Scholar
• Cerny-Reiterer S, Rabenhorst A, Stefanzl G, et al. Long-term treatment with imatinib results in profound mast cell deficiency in Ph+ chronic myeloid leukemia. Oncotarget. 2015;6(5):3071–3084.
   PubMedGoogle Scholar
• Dahlin JS, Maurer M, D D, Metcalfe . The ingenious mast cell: contemporary insights into mast cell behavior and function. Allergy; 2022. 77(1):83-99.
   Google Scholar
• Katsoulis-Dimitriou K, Kotrba J, Voss M, et al. Mast cell functions linking innate sensing to adaptive immunity. Cells. 2020;9(12):2538.
   PubMed Web of Science ®Google Scholar
• Navinés-Ferrer A, Serrano-Candelas E, Lafuente A, et al. MRGPRX2-mediated mast cell response to drugs used in perioperative procedures and anaesthesia. Sci Rep. 2018;8(1):11628.
   PubMed Web of Science ®Google Scholar
• Galli SJ, Tsai M. IgE and mast cells in allergic disease. Nat Med. 2012;18(5):693–704.
   PubMed Web of Science ®Google Scholar
• Che D, Hou Y, Zeng Y, et al. Dehydroandrographolide inhibits IgE-mediated anaphylactic reactions via calcium signaling pathway. Toxicol Appl Pharmacol. 2019;366:46–53.
   PubMed Web of Science ®Google Scholar
• Lee HJ, Seo H S, Kim G J. Houttuynia cordata Thunb inhibits the production of pro‑inflammatory cytokines through inhibition of the NFκB signaling pathway in HMC‑1 human mast cells. Mol Med Rep. 2013;8(3):731–736.
   PubMed Web of Science ®Google Scholar
• Dale P, Head V, Dowling M R. Selective inhibition of histamine-evoked Ca2+ signals by compartmentalized cAMP in human bronchial airway smooth muscle cells. Vol. 71. Cell Calcium; 2018. p. 53–64.
   Google Scholar
• Haick JM, Brueggemann L I, Cribbs L L. PKC-dependent regulation of Kv7.5 channels by the bronchoconstrictor histamine in human airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol. 2017;312(6):L822–L834.
   PubMed Web of Science ®Google Scholar
• Steelant B, Seys SF, Van Gerven L, et al. Histamine and T helper cytokine-driven epithelial barrier dysfunction in allergic rhinitis. J Allergy Clin Immunol. 2018;141(3):951–963.e8.
   PubMed Web of Science ®Google Scholar
• Kang B, Park J-H, and Lee H-M. Histamine induced production of chemokine CXCL8 through H1R/PLC and NF-κB signaling pathways in nasal fibroblasts Journal of Rhinology . 2020;27(2):95–101.
   Google Scholar
• Kordulewska NK, Kostyra E, Cieślińska A, et al. Changes in gene expression induced by histamine, fexofenadine and osthole: expression of histamine H1 receptor, COX-2, NF-κB, CCR1, chemokine CCL5/RANTES and interleukin-1β in PBMC allergic and non-allergic patients. Immunobiology. 2017;222(3):571–581.
   PubMed Web of Science ®Google Scholar
• Groeger M, Spanier G, Wolf M, et al. Effects of histamine on human periodontal ligament fibroblasts under simulated orthodontic pressure. PLOS ONE. 2020;15(8):e0237040.
   PubMed Web of Science ®Google Scholar
• Mommert S, Gregor K, Rossbach K, et al. Histamine H2 receptor stimulation upregulates TH2 chemokine CCL17 production in human M2a macrophages. J Allergy Clin Immunol. 2018;141(2):782–785.e5.
   PubMed Web of Science ®Google Scholar
• Kang JW, Lee YH, Kang MJ, et al. Synergistic mucus secretion by histamine and IL-4 through TMEM16A in airway epithelium. Am J Physiol Lung Cell Mol Physiol. 2017;313(3):L466–L476.
   PubMed Web of Science ®Google Scholar
• Chen X, Zhang Z, Dou X, et al. Histamine H4 Receptor mediates interleukin-; 8 and TNF-α release in human mast cells via multiple signaling pathways. Cell Mol Biol. 2016;62(1):84–89.
   PubMed Web of Science ®Google Scholar
• Kay LJ, Suvarna SK, Peachell PT. Histamine H4 receptor mediates chemotaxis of human lung mast cells. Eur J Pharmacol. 2018;837:38–44.
   PubMed Web of Science ®Google Scholar
• Lord MS, Jung M, Whitelock JM. Optimization of bioengineered heparin/heparan sulfate production for therapeutic applications. Bioengineered. 2017;8(5):661–664.
   PubMed Web of Science ®Google Scholar
• Gross AR, Theoharides TC. Chondroitin sulfate inhibits secretion of TNF and CXCL8 from human mast cells stimulated by IL-33. BioFactors. 2019;45(1):49–61.
   PubMed Web of Science ®Google Scholar
• Dichlberger A, Petri TK, Wolfgang JS. Mast cells: from lipid droplets to lipid mediators. Clin Sci. 2013;125(3):121–130.
   Web of Science ®Google Scholar
• Baothman BK, Smith J, Kay LJ, et al. Prostaglandin D2 generation from human lung mast cells is catalysed exclusively by cyclooxygenase-1. Eur J Pharmacol. 2018;819:225–232.
   PubMed Web of Science ®Google Scholar
• Johnsson A-K, Choi J-H, Rönnberg E, et al. Selective inhibition of prostaglandin D 2 biosynthesis in human mast cells to overcome need for multiple receptor antagonists: biochemical consequences. Clin Exp Allergy. 2021;51(4):594–603.
   PubMed Web of Science ®Google Scholar
• Carstensen S, Gress C, Erpenbeck VJ, et al. Prostaglandin D2 metabolites activate asthmatic patient-derived type 2 innate lymphoid cells and eosinophils via the DP2 receptor. Respir Res. 2021;22(1):262.
   PubMed Web of Science ®Google Scholar
• Kolmert J, Gómez C, Balgoma D, et al. Urinary leukotriene E 4 and prostaglandin D 2 metabolites increase in adult and childhood severe asthma characterized by type 2 inflammation. A Clinical Observational Study. American Journal of Respiratory and Critical Care Medicine. 2021;203(1):37–53.
   PubMed Web of Science ®Google Scholar
• Bochenek G, Nagraba K, Niżankowska E, et al. A controlled study of 9α,11β-PGF2 (a prostaglandin D2 metabolite) in plasma and urine of patients with bronchial asthma and healthy controls after aspirin challenge. J Allergy Clin Immunol. 2003;111(4):743–749.
   PubMed Web of Science ®Google Scholar
• Suto W, Ando Y, Hirabayashi T, et al. Prostaglandin D2 induces ca2+ sensitization of contraction without affecting cytosolic ca2+ level in bronchial smooth muscle. Int J Mol Sci. 2018;19(10):3036.
   PubMed Web of Science ®Google Scholar
• Yang SJ, Allahverdian S, Saunders ADR, et al. IL-13 signaling through IL-13 receptor α2 mediates airway epithelial wound repair. FASEB J. 2019;33(3):3746–3757.
   PubMed Web of Science ®Google Scholar
• Grabauskas G, Wu X, Gao J, et al. Prostaglandin E2, produced by mast cells in colon tissues from patients with irritable bowel syndrome, contributes to visceral hypersensitivity in mice. Gastroenterology. 2020;158(8):2195–2207.e6.
   PubMed Web of Science ®Google Scholar
• Rastogi S, Willmes DM, Nassiri M, et al. PGE2 deficiency predisposes to anaphylaxis by causing mast cell hyperresponsiveness. J Allergy Clin Immunol. 2020;146(6):1387–1396.e13.
   PubMed Web of Science ®Google Scholar
• Maric J, Ravindran A, Mazzurana L, et al. Prostaglandin E2 suppresses human group 2 innate lymphoid cell function. J Allergy Clin Immunol. 2018;141(5):1761–1773.e6.
   PubMed Web of Science ®Google Scholar
• Johnsson A-K, Rönnberg E, Fuchs D, et al. COX-1 dependent biosynthesis of 15-hydroxyeicosatetraenoic acid in human mast cells. biochimica et biophysica acta (BBA). Molecular and Cell Biology of Lipids. 2021;1866(5):158886.
   PubMed Web of Science ®Google Scholar
• Tsai M-J, Wang T-N, Lin Y-S, et al. Aryl hydrocarbon receptor agonists upregulate VEGF secretion from bronchial epithelial cells. J Mol Med. 2015;93(11):1257–1269.
   PubMed Web of Science ®Google Scholar
• Zhao J, Minami Y, Etling E, et al. Preferential generation of 15-HETE-PE induced by IL-13 regulates goblet cell differentiation in human airway epithelial cells. Am J Respir Cell Mol Biol. 2017;57(6):692–701.
   PubMed Web of Science ®Google Scholar
• Varricchi G, Pecoraro A, Loffredo S, et al. Heterogeneity of human mast cells with respect to MRGPRX2 receptor expression and function. Front Cell Neurosci. 2019;13(299). DOI:10.3389/fncel.2019.00299.
   PubMedGoogle Scholar
• Weng Z, Zhang B, Asadi S, and Quercetin is more effective than cromolyn in blocking human mast cell cytokine release and inhibits contact dermatitis and photosensitivity in humans. PLOS ONE. 2012;7(3):e33805.
   PubMed Web of Science ®Google Scholar
• Dunne AE, Kawamatawong T, Fenwick PS, et al. Direct inhibitory effect of the pde4 inhibitor roflumilast on neutrophil migration in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol. 2019;60(4):445–453.
   PubMed Web of Science ®Google Scholar
• O’Dwyer CA, O’Brien ME, Wormald MR, et al. The BLT1 inhibitory function of α-1 antitrypsin augmentation therapy disrupts leukotriene B 4 neutrophil signaling. J Immunol. 2015;195(8):3628–3641.
   PubMed Web of Science ®Google Scholar
• Wang M, et al. Differential contribution of BLT1 and BLT2 to leukotriene B4-Induced human NK cell cytotoxicity and migration. Mediators of Inflammation. 2015;389849.
   PubMed Web of Science ®Google Scholar
• Weller CL, Collington SJ, Brown JK, et al. Leukotriene B4, an activation product of mast cells, is a chemoattractant for their progenitors. J Exp Med. 2005;201(12):1961–1971.
   PubMed Web of Science ®Google Scholar
• Poulin S, Thompson C, Thivierge M, et al. Cysteinyl-leukotrienes induce vascular endothelial growth factor production in human monocytes and bronchial smooth muscle cells. Clin Exp Allergy. 2011;41(2):204–217.
   PubMed Web of Science ®Google Scholar
• Lazarinis N, Bood J, Gomez C, et al. Leukotriene E4 induces airflow obstruction and mast cell activation through the cysteinyl leukotriene type 1 receptor. J Allergy Clin Immunol. 2018;142(4):1080–1089.
   PubMed Web of Science ®Google Scholar
• Salimi M, Stöger L, Liu W, et al. Cysteinyl leukotriene E4 activates human group 2 innate lymphoid cells and enhances the effect of prostaglandin D2 and epithelial cytokines. J Allergy Clin Immunol. 2017;140(4):1090–1100.e11.
   PubMed Web of Science ®Google Scholar
• Oskeritzian CA, Zhao W, Min H K. Surface CD88 functionally distinguishes the MCTC from the MCT type of human lung mast cell. J Allergy Clin Immunol. 2005;115(6):1162–1168.
   PubMed Web of Science ®Google Scholar
• Kondeti V, Al-Azzam N, Duah E, et al. Leukotriene D4 and prostaglandin E2 signals synergize and potentiate vascular inflammation in a mast cell-dependent manner through cysteinyl leukotriene receptor 1 and E-prostanoid receptor 3. J Allergy Clin Immunol. 2016;137(1):289–298.
   PubMed Web of Science ®Google Scholar
• Hilvering B, Hinks TSC, Stöger L, et al. Synergistic activation of pro-inflammatory type-2 CD8+ T lymphocytes by lipid mediators in severe eosinophilic asthma. Mucosal Immunol. 2018;11(5):1408–1419.
   PubMed Web of Science ®Google Scholar
• Irani A-MA, Schwartz LB. Human mast cell heterogeneity. Allergy Asthma Proc. 1994;15(6):303–308.
   Google Scholar
• Siddhuraj P, Clausson C-M, Sanden C, et al. Lung mast cells have a high constitutive expression of carboxypeptidase A3 mRNA that is independent from granule-stored CPA3. Cells. 2021;10(2):309.
   PubMed Web of Science ®Google Scholar
• Andersson CK, Mori M, Bjermer L, et al. Novel site-specific mast cell subpopulations in the human lung. Thorax. 2009;64(4):297–305.
   PubMed Web of Science ®Google Scholar
• Berlin F, Mogren S, Tutzauer J, et al. Mast cell proteases tryptase and chymase induce migratory and morphological alterations in bronchial epithelial cells. Int J Mol Sci. 2021;22(10):5250.
   PubMed Web of Science ®Google Scholar
• Ramu S, Akbarshahi H, Mogren S, et al. Direct effects of mast cell proteases, tryptase and chymase, on bronchial epithelial integrity proteins and anti-viral responses. BMC Immunol. 2021;22(1):35.
   PubMed Web of Science ®Google Scholar
• Zhao XO, Lampinen M, Rollman O. , and Mast cell chymase affects the functional properties of primary human airway fibroblasts: implications for asthma. J Allergy Clin Immunol. 2021;149(2):718-727.
   Web of Science ®Google Scholar
• Maun HR, Jackman JK, Choy DF, et al. An allosteric anti-tryptase antibody for the treatment of mast cell-mediated severe asthma. Cell. 2019;179(2):417–431.e19.
   PubMed Web of Science ®Google Scholar
• Mogren S, Berlin F, Ramu S, et al. Mast cell tryptase enhances wound healing by promoting migration in human bronchial epithelial cells. Cell Adh Migr. 2021;15(1):202–214.
   PubMed Web of Science ®Google Scholar
• Fu Z, Akula S, Thorpe M, et al. Highly selective cleavage of TH2-Promoting cytokines by the human and the mouse mast cell tryptases, indicating a potent negative feedback loop on TH2 immunity. Int J Mol Sci. 2019;20(20):5147.
   PubMed Web of Science ®Google Scholar
• Miyagawa Y, Murakami A, Ebihara N. The proteolytic effect of mast cell tryptase to eotaxin-1/CCL11·eotaxin-2/CCL24 and eotaxin-3/CCL26 produced by conjunctival fibroblasts. Jpn J Ophthalmol. 2019;63(2):215–220.
   PubMed Web of Science ®Google Scholar
• Maaninka K, et al. Human mast cell neutral proteases generate modified LDL particles with increased proteoglycan binding. Atherosclerosis. 2018;275:390–399.
   PubMed Web of Science ®Google Scholar
• Ahmad S, Wright KN, Sun X, et al. Mast cell peptidases (carboxypeptidase A and chymase)-mediated hydrolysis of human angiotensin-(1–12) substrate. Biochem Biophys Res Commun. 2019;518(4):651–656.
   PubMed Web of Science ®Google Scholar
• Fu Z, Thorpe M, Alemayehu R, et al. Highly selective cleavage of cytokines and chemokines by the human mast cell chymase and neutrophil cathepsin G. J Immunol. 2017;198(4):1474.
   PubMed Web of Science ®Google Scholar
• Kushnir-Sukhov NM, Brown JM, Wu Y, et al. Human mast cells are capable of serotonin synthesis and release. J Allergy Clin Immunol. 2007;119(2):498–499.
   PubMed Web of Science ®Google Scholar
• Mendez-Enriquez E, Alvarado‐Vazquez PA, Abma W, et al. Mast cell-derived serotonin enhances methacholine-induced airway hyperresponsiveness in house dust mite-induced experimental asthma. Allergy. 2021;76(7):2057–2069.
   PubMed Web of Science ®Google Scholar
• Lau WKW, Cui LY, Chan SCH, et al. The presence of serotonin in cigarette smoke – a possible mechanistic link to 5-HT-induced airway inflammation. Free Radic Res. 2016;50(5):495–502.
   PubMed Web of Science ®Google Scholar
• Löfdahl A, Wenglén C, Rydell-Törmänen K, et al. Effects of 5-hydroxytryptamine class 2 receptor antagonists on bronchoconstriction and pulmonary remodeling processes. Am J Pathol. 2018;188(5):1113–1119.
   PubMed Web of Science ®Google Scholar
• Han X, Chen C, Cheng G. Peroxisome proliferator-activated receptor γ attenuates serotonin-induced pulmonary artery smooth muscle cell proliferation and apoptosis inhibition involving ERK1/2 pathway. Vol. 100. Microvascular Research; 2015. p. 17–24.
   Google Scholar
• Domínguez-Soto Á, Usategui A, Casas-Engel MDL, et al. Serotonin drives the acquisition of a profibrotic and anti-inflammatory gene profile through the 5-HT7R-PKA signaling axis. Sci Rep. 2017;7(1):14761.
   PubMedGoogle Scholar
• Okragly AJ, Morin SM, DeRosa D, et al. Human mast cells release the migraine-inducing factor pituitary adenylate cyclase-activating polypeptide (PACAP). Cephalalgia. 2018;38(9):1564–1574.
   PubMed Web of Science ®Google Scholar
• Chiba Y, Ueda C, Kohno N, et al. Attenuation of relaxing response induced by pituitary adenylate cyclase-activating polypeptide in bronchial smooth muscle of experimental asthma. Am J Physiol Lung Cell Mol Physiol. 2020;319(5):L786–L793.
   PubMed Web of Science ®Google Scholar
• Yoshihara S, Yamada Y, Abe T, et al. Long-lasting smooth-muscle relaxation by a novel PACAP analogue in human bronchi. Regul Pept. 2004;123(1):161–165.
   PubMedGoogle Scholar
• Kubysheva N, Boldina M, Eliseeva T Relationship of serum levels of IL-17, IL-18, TNF-α, and lung function parameters in patients with COPD, asthma-COPD overlap, and bronchial asthma. Vol. 2020. Mediators of Inflammation; 2020. p. 4652898.
   Google Scholar
• Ren X, Han L, Li Y, et al. Isorhamnetin attenuates TNF‐α‐induced inflammation, proliferation, and migration in human bronchial epithelial cells via MAPK and NF‐κB pathways. The Anatomical Record. 2021;304(4):901–913.
   Google Scholar
• Bazan-Socha S, Mastalerz L, Cybulska A, et al. Prothrombotic state in asthma is related to increased levels of inflammatory cytokines, IL-6 and TNFα, in peripheral blood. Inflammation. 2017;40(4):1225–1235.
   PubMed Web of Science ®Google Scholar
• Wu S, Li H, Yu L, et al. IL-1β upregulates Muc5ac expression via NF-κB-induced HIF-1α in asthma. Immunol Lett. 2017;192:20–26.
   PubMed Web of Science ®Google Scholar
• Golebski K, Ros XR, Nagasawa M, et al. IL-1β, IL-23, and TGF-β drive plasticity of human ILC2s towards IL-17-producing ILCs in nasal inflammation. Nat Commun. 2019;10(1):2162.
   PubMedGoogle Scholar
• Zou Y, Chen X, Liu J, et al. Serum IL-1β and IL-17 levels in patients with COPD: associations with clinical parameters. Int J Chron Obstruct Pulmon Dis. 2017;12:1247–1254.
   PubMed Web of Science ®Google Scholar
• Manson ML, Säfholm J, James A, et al. IL-13 and IL-4, but not IL-5 nor IL-17A, induce hyperresponsiveness in isolated human small airways. J Allergy Clin Immunol. 2020;145(3):808–817. e2.
   PubMed Web of Science ®Google Scholar
• Chu DK, Al-Garawi A, Llop-Guevara A, et al. Therapeutic potential of anti-IL-6 therapies for granulocytic airway inflammation in asthma. Allergy. Asthma Clin Immunol. 2015;11(1):14.
   PubMed Web of Science ®Google Scholar
• Cao L, Liu F, Liu Y, et al. TSLP promotes asthmatic airway remodeling via p38-STAT3 signaling pathway in human lung fibroblast. Exp Lung Res. 2018;44(6):288–301.
   PubMed Web of Science ®Google Scholar
• Desai A, Jung M Y, Olivera A. IL-6 promotes an increase in human mast cell numbers and reactivity through suppression of suppressor of cytokine signaling 3. J Allergy Clin Immunol. 2016;137(6):1863–1871.
   PubMed Web of Science ®Google Scholar
• Huang N, Liu K, Liu J. Interleukin-37 alleviates airway inflammation and remodeling in asthma via inhibiting the activation of NF-κB and STAT3 signalings. Vol. 55. Journal article: International Immunopharmacology; 2018. p. 198–204.
   Google Scholar
• Jevnikar Z, et al. Epithelial IL-6 trans-signaling defines a new asthma phenotype with increased airway inflammation. J Allergy Clin Immunol. 2019;143(2):577–590.
   PubMed Web of Science ®Google Scholar
• Kim J, Chang Y, Bae B, et al. Innate immune crosstalk in asthmatic airways: innate lymphoid cells coordinate polarization of lung macrophages. J Allergy Clin Immunol. 2019;143(5):1769–1782. e11.
   PubMed Web of Science ®Google Scholar
• Suzuki Y, Wakahara K, Nishio T, et al. Airway basophils are increased and activated in eosinophilic asthma. Allergy. 2017;72(10):1532–1539.
   PubMed Web of Science ®Google Scholar
• Emi-Sugie M, Saito H, Matsumoto K. Cultured human mast cells release various chemokines after stimulation with IL-33. Allergol Int. 2021;70(3):386–388.
   PubMed Web of Science ®Google Scholar
• Jayapal M, Tay H K, Reghunathan R. Genome-wide gene expression profiling of human mast cells stimulated by IgE or FcεRI-aggregation reveals a complex network of genes involved in inflammatory responses. BMC Genomics . 2006;7(1):1–17.
   PubMedGoogle Scholar
• Kobayashi Y, Konno Y, Kanda A, et al. Critical role of CCL4 in eosinophil recruitment into the airway. Clin Exp Allergy. 2019;49(6):853–860.
   PubMed Web of Science ®Google Scholar
• Williams AE, Jose RJ, Mercer P F. Evidence for chemokine synergy during neutrophil migration in ARDS. Thorax. 2017;72(1):66–73.
   PubMed Web of Science ®Google Scholar
• Cen S, Wang P, Xie Z, et al. Autophagy enhances mesenchymal stem cell-mediated CD4+ T cell migration and differentiation through CXCL8 and TGF-β1. Stem Cell Res Ther. 2019;10(1):265.
   PubMed Web of Science ®Google Scholar
• Li Y, Zheng Y, Li T, et al. Chemokines CCL2, 3, 14 stimulate macrophage bone marrow homing, proliferation, and polarization in multiple myeloma. Oncotarget. 2015;6(27):24218–24229.
   PubMed Web of Science ®Google Scholar
• Monzon ME, Forteza RM, Casalino-Matsuda SM. MCP-1/CCR2B-dependent loop upregulates MUC5AC and MUC5B in human airway epithelium. Am J Physiol Lung Cell Mol Physiol. 2011;300(2):L204–L215.
   PubMed Web of Science ®Google Scholar
• Knipfer L, Schulz-Kuhnt A, Kindermann M, et al. A CCL1/CCR8-dependent feed-forward mechanism drives ILC2 functions in type 2–mediated inflammation. J Exp Med. 2019;216(12):2763–2777.
   PubMed Web of Science ®Google Scholar
• Allard B, Levardon H, Esteves P, et al. Asthmatic bronchial smooth muscle increases CCL5-Dependent monocyte migration in response to rhinovirus-infected epithelium. Front Immunol. 2020;10(2998). DOI:10.3389/fimmu.2019.02998.
   PubMedGoogle Scholar
• Mills SC, Howell L, Beekman A. Rac1 plays a role in CXCL12 but not CCL3-induced chemotaxis and Rac1 GEF inhibitor NSC23766 has off target effects on CXCR4. Vol. 42. Journal article: Cellular Signalling; 2018. p. 88–96.
   Google Scholar
• Al-Alwan LA, Chang Y, Mogas A, et al. Differential roles of CXCL2 and CXCL3 and their receptors in regulating normal and asthmatic airway smooth muscle cell migration. J Immunol. 2013;191(5):2731–2741.
   PubMed Web of Science ®Google Scholar
• Cristinziano L, Poto R, Criscuolo G, et al. IL-33 and superantigenic activation of human lung mast cells induce the release of angiogenic and lymphangiogenic factors. Cells. 2021;10(1):145.
   PubMed Web of Science ®Google Scholar
• McHale C, Mohammed Z, Deppen J, et al. Interleukin-6 potentiates FcεRI-induced PGD2 biosynthesis and induces VEGF from human in situ-matured skin mast cells. Biochimica et biophysica acta (BBA. General Subjects. 2018;1862(5):1069–1078.
   PubMed Web of Science ®Google Scholar
• Molnár V, Érsek B, Wiener Z, et al. MicroRNA-132 targets HB-EGF upon IgE-mediated activation in murine and human mast cells. Cell Mol Life Sci. 2012;69(5):793–808.
   PubMed Web of Science ®Google Scholar
• Li Y, Su G, Zhong Y, et al. HB-EGF-induced IL-8 secretion from airway epithelium leads to lung fibroblast proliferation and migration. BMC Pulm Med. 2021;21(1):347.
   PubMed Web of Science ®Google Scholar
• Grigoras A, Căruntu ID, Grigoraş CC, et al. Relationship between immunohistochemical assessment of bronchial mucosa microvascularization and clinical stage in asthma. Rom J Morphol Embryol. 2012;53(3):485–490.
   PubMed Web of Science ®Google Scholar
• Kim S-H, Pei Q-M, Jiang P, et al. Upregulation of MUC5AC by VEGF in human primary bronchial epithelial cells: implications for asthma. Respir Res. 2019;20(1):282.
   PubMed Web of Science ®Google Scholar
• Zhang J, Cui J, Li X, et al. Increased secretion of VEGF-C from SiO2-induced pulmonary macrophages promotes lymphangiogenesis through the Src/eNOS pathway in silicosis. Ecotoxicol Environ Saf. 2021;218:112257.
   PubMed Web of Science ®Google Scholar
• Ebina M. Remodeling of airway walls in fatal asthmatics decreases lymphatic distribution; beyond thickening of airway smooth muscle layers. Allergol Int. 2008;57(2):165–174.
   PubMedGoogle Scholar
• Däbritz J, et al. Reprogramming of monocytes by gm-csf contributes to regulatory immune functions during intestinal inflammation. J Immunol. 2015;194(5):2424.
   PubMed Web of Science ®Google Scholar
• Reece P, Baatjes AJ, Cyr MM, et al. Toll-like receptor-mediated eosinophil–basophil differentiation: autocrine signalling by granulocyte–macrophage colony-stimulating factor in cord blood haematopoietic progenitors. Immunology. 2013;139(2):256–264.
   PubMed Web of Science ®Google Scholar
• Overgaard CE, Schlingmann B, Dorsainvil White S, et al. The relative balance of GM-CSF and TGF-β1 regulates lung epithelial barrier function. Am J Physiol Lung Cell Mol Physiol. 2015;308(12):L1212–L1223.
   PubMed Web of Science ®Google Scholar
• van Riet S, Van schadewijk A, De vos S, et al. Modulation of airway epithelial innate immunity and wound repair by M(GM-CSF) and M(M-CSF) macrophages. J Innate Immun. 2020;12(5):410–421.
   PubMed Web of Science ®Google Scholar
• Vogel DYS, Kooij G, Heijnen PDAM, et al. GM-CSF promotes migration of human monocytes across the blood brain barrier. Eur J Immunol. 2015;45(6):1808–1819.
   PubMed Web of Science ®Google Scholar
• Frieri M. Mast cell activation syndrome. Clin Rev Allergy Immunol. 2018;54(3):353–365.
   PubMed Web of Science ®Google Scholar
• Haenisch B, Nöthen MM, Molderings GJ. Systemic mast cell activation disease: the role of molecular genetic alterations in pathogenesis, heritability and diagnostics. Immunology. 2012;137(3):197–205.
   PubMed Web of Science ®Google Scholar
• Afrin LB, Weinstock LB, Molderings GJ. Covid-19 hyperinflammation and post-Covid-19 illness may be rooted in mast cell activation syndrome. Inter J Infect Dis. 2020;100:327–332.
   PubMed Web of Science ®Google Scholar
• Gebremeskel S, Schanin J, Coyle KM, et al. Mast cell and eosinophil activation are associated with COVID-19 and TLR-Mediated viral inflammation: implications for an anti-siglec-8 antibody. Front Immunol. 2021;12(641). DOI:10.3389/fimmu.2021.650331.
   PubMedGoogle Scholar
• Liu Z, Zhu Y, Xu L, et al. Tumor stroma-infiltrating mast cells predict prognosis and adjuvant chemotherapeutic benefits in patients with muscle invasive bladder cancer. OncoImmunology. 2018;7(9):e1474317.
   PubMed Web of Science ®Google Scholar
• Mao Y, Feng Q, Zheng P, et al. Low tumor infiltrating mast cell density confers prognostic benefit and reflects immunoactivation in colorectal cancer. Int J Cancer. 2018;143(9):2271–2280.
   PubMed Web of Science ®Google Scholar
• McHale C, Mohammed Z, Gomez G. Human skin-derived mast cells spontaneously secrete several angiogenesis-related factors. Front Immunol. 2019;10(1445). 10.3389/fimmu.2019.01445
   PubMedGoogle Scholar
• Plotkin JD, Efroni S, Fereydouni M . Human mast cells from adipose tissue target and induce apoptosis of breast cancer cells. Front Immunol. 2019;10:10.
   PubMed Web of Science ®Google Scholar
• Brightling C, Kulkarni S, Lambrecht B N. The pharmacology of the prostaglandin D2 receptor 2 (DP2) receptor antagonist, fevipiprant. Vol. 68. Journal article: Pulmonary Pharmacology & Therapeutics; 2021. p. 102030.
   Google Scholar
• Lemal R, Fouquet G, Terriou L, et al. Omalizumab therapy for mast cell-mediator symptoms in patients with ISM, CM, MMAS, and MCAS. J Allergy Clin Immunol. 2019;7(7):2387–2395.e3.
   Web of Science ®Google Scholar
• Afrin LB, Fox RW, Zito SL, et al. Successful targeted treatment of mast cell activation syndrome with tofacitinib. Eur J Haematol. 2017;99(2):190–193.
   PubMed Web of Science ®Google Scholar
• Li Y, Liu X, Yu J. Tofacitinib suppresses mast cell degranulation and attenuates experimental allergic conjunctivitis. Vol. 86. Journal article: International Immunopharmacology; 2020. p. 106737.
   Google Scholar
• Mukai K, Tsai M, Saito H, et al. Mast cells as sources of cytokines, chemokines, and growth factors. Immunol Rev. 2018;282(1):121–150.
   PubMed Web of Science ®Google Scholar
• Wang G, Cheng N. Paeoniflorin inhibits mast cell–mediated allergic inflammation in allergic rhinitis. J Cell Biochem. 2018;119(10):8636–8642.
   PubMed Web of Science ®Google Scholar
• Kim -Y-Y, Hur G, Lee SW, et al. AGK2 ameliorates mast cell-mediated allergic airway inflammation and fibrosis by inhibiting FcεRI/TGF-β signaling pathway. Pharmacol Res. 2020;159:105027.
   PubMed Web of Science ®Google Scholar
• Toru H, Pawankar R, Ra C, et al. Human mast cells produce IL-13 by high-affinity IgE receptor cross-linking: enhanced IL-13 production by IL-4–primed human mast cells. J Allergy Clin Immunol. 1998;102(3):491–502.
   PubMed Web of Science ®Google Scholar
• Cao J, Li C, Ma P. Effect of kaempferol on IgE-mediated anaphylaxis in C57BL/6 mice and LAD2 cells. Vol. 79. Journal article: Phytomedicine; 2020. p. 153346.
   Google Scholar